“The existing predicament has exposed some structural weaknesses in the EU’s medicines source chain in addition to a higher dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides claimed. She suggested that supply chain troubles be resolved in an EU pharmaceutical technique anticipated to become relea